Drug use and opioid substitution treatment for prisoners

被引:51
|
作者
Stoever, Heino [1 ]
Michels, Ingo Ilja [2 ]
机构
[1] Univ Appl Sci, Res Inst Addict, D-60318 Frankfurt, Germany
[2] Deutsch Gesell Tech Zusammenarbeit GTZ, Cent Asia Drug Act Programme CADAP European Union, Bishkek, Kyrgyzstan
关键词
METHADONE-MAINTENANCE TREATMENT; RANDOMIZED CONTROLLED-TRIAL; HEPATITIS-C; BUPRENORPHINE; TRANSMISSION; RISK; HIV; ATTITUDES; INJECTION;
D O I
10.1186/1477-7517-7-17
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Drug use is prevalent throughout prison populations, and, despite advances in drug treatment programmes for inmates, access to and the quality of these programmes remain substantially poorer than those available for non-incarcerated drug users. Because prisoners may be at greater risk for some of the harms associated with drug use, they deserve therapeutic modalities and attitudes that are at least equal to those available for drug users outside prison. This article discusses drug use by inmates and its associated harms. In addition, this article provides a survey of studies conducted in prisons of opioid substitution therapy (OST), a clinically effective and cost-effective drug treatment strategy. The findings from this overview indicate why treatment efforts for drug users in prison are often poorer than those available for drug users in the non-prison community and demonstrate how the implementation of OST programmes benefits not only prisoners but also prison staff and the community at large. Finally, the article outlines strategies that have been found effective for implementing OST in prisons and offers suggestions for applying these strategies more broadly.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Enacted Stigma From Family and Drug Use During Opioid Use Disorder Treatment
    Earnshaw, Valerie A.
    Brousseau, Natalie M.
    Hill, E. Carly
    Laurenceau, Jean-Philippe
    Sepucha, Karen R.
    Qiu, Xueli
    Mousavi, Mohammad
    Morrison, Lynn M.
    Kelly, John F.
    STIGMA AND HEALTH, 2024,
  • [42] Prescription Drug Use among Pregnant Women in Opioid Maintenance Treatment
    Lund, Ingunn Olea
    Engeland, Anders
    Kari, Furu
    Edle, Ravndal
    Skurtveit, Svetlana
    Marte, Handal
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 388 - 388
  • [43] Patterns of drug use in dependent opioid users in methadone treatment.
    Chamberlain, N
    NEW ZEALAND MEDICAL JOURNAL, 1997, 110 (1047) : 258 - 259
  • [44] ITI-333: An Investigational Drug for the Treatment of Opioid Use Disorder
    Vanover, Kimberly
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 51 - 52
  • [45] Acute Burn Treatment and History of Drug and Alcohol Addiction: Treatment Outcomes and Opioid Use
    Duraes, Eliana F. R.
    Hung, Ya-Ching
    Asif, Mohammed
    Modica, Ashley
    Sikorski, Giulia
    Hultman, Charles S.
    Caffrey, Julie
    EUROPEAN BURN JOURNAL, 2022, 3 (01): : 10 - 17
  • [46] Opioid substitution and HIV/AIDS treatment and prevention
    Kerr, T
    Wodak, A
    Elliott, R
    Montaner, JS
    Wood, E
    LANCET, 2004, 364 (9449): : 1918 - 1919
  • [47] Gender differences among prisoners in drug treatment
    Langan, NP
    Pelissier, BMM
    JOURNAL OF SUBSTANCE ABUSE, 2001, 13 (03) : 291 - 301
  • [48] Economic evaluation of opioid substitution treatment in Greece
    Geitona, Mary
    Carayanni, Vilelmine
    Petratos, Pythagoras
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2012, 14 (03) : 77 - 88
  • [49] Injectable heroin substitution treatment for opioid dependency
    Drucker, E
    LANCET, 2001, 358 (9291): : 1385 - 1385
  • [50] Opioid substitution therapy: Lowering the treatment thresholds
    Kourounis, Georgios
    Richards, Brian David Wensley
    Kyprianou, Evdokia
    Symeonidou, Eva
    Malliori, Minerva-Melpomeni
    Samartzis, Lampros
    DRUG AND ALCOHOL DEPENDENCE, 2016, 161 : 1 - 8